IQVIA Earnings & Revenues Surpass Estimates in Q4, Increase Y/Y

06.02.25 18:48 Uhr

Werte in diesem Artikel
Aktien

190,40 EUR -3,20 EUR -1,65%

Indizes

6.049,3 PKT -19,2 PKT -0,32%

IQVIA Holdings Analytics Inc. IQV has reported impressive fourth-quarter 2024 results, wherein earnings and revenues beat the Zacks Consensus Estimate.See Zacks Earnings Calendar to stay ahead of market-making news.Adjusted earnings were $3.12 per share, outpacing the Zacks Consensus Estimate marginally and rising 9.9% on a year-over-year basis. Total revenues of $4 billion surpassed the consensus estimate by a slight margin and grew 2.3% from the year-ago quarter.The IQV stock has declined 10.5% over the past six months against the 9.8% rally of the industry it belongs to and 17.4% growth of the Zacks S&P 500 Composite.IQVIA Holdings Inc. Price, Consensus and EPS Surprise  IQVIA Holdings Inc. price-consensus-eps-surprise-chart | IQVIA Holdings Inc. QuoteIQVIA’s Quarterly DetailsThe Research and Development segment’s revenues were $2.1 billion, increasing 1.3% from the year-ago quarter and 1% on a constant-currency basis. This metric missed our estimate of $2.2 billion and increased 9.5% on a constant-currency basis.Revenues from the Technology and Analytics segment were $1.7 billion, growing 8.3% from the year-ago quarter and 9.5% on a constant-currency basis. The metric beat our estimate of $1.6 billion and increased 10.6% on a constant-currency basis.Contract Sales & Medical Solutions revenues decreased 4.8% on a year-over-year basis to $177 million and increased 3.2% on a constant-currency basis. The metric missed our projection of $187 million and declined 11.1% on a constant-currency basis.Adjusted EBITDA for the fourth quarter of 2024 was $996 million, indicating a 3.1% rise from the year-ago quarter and lagging our projection of $1 billion.The company exited the quarter with cash and cash equivalents of $1.7 billion compared with $1.6 billion at the end of the preceding quarter. Long-term debt (less current portion) was $12.8 billion compared with $12.3 billion at the end of the third quarter of 2024.Net cash generated from operating activities was $885 million and the capital expenditure for the quarter was $164 million. The company generated a free cash flow of $721 million in the quarter.IQV’s 2025 GuidanceFor 2025, IQVIA has raised its revenue guidance to $15.72-$16.12 billion from the preceding quarter’s view of $15.35-$15.40 billion. The mid-point ($15.92 billion) of the guided range is lower than the Zacks Consensus Estimate for revenues pegged at $16.02 billion.The company has hiked the adjusted EPS guidance to $11.70-$12.10 from the previous quarter’s view of $11.10-$11.20. The mid-point ($11.9) of the guided range is higher than the Zacks Consensus Estimate for earnings pegged at $11.8 per share.The company’s adjusted EBITDA view for the same period has been raised to $3.76-$3.88 billion compared with the preceding quarter’s view of $3.67-$3.70 billion.IQV carries a Zacks Rank #3 (Hold) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.Earnings SnapshotGartner, Inc. IT reported better-than-expected fourth-quarter 2024 results.IT’s adjusted earnings per share of $5.6 beat the Zacks Consensus Estimate by 69.3% and increased 79.3% from the year-ago quarter. Revenues of $1.7 billion surpassed the consensus estimate by 1.8% and improved 8.2% year over year.Broadridge Financial Solutions, Inc. BR posted impressive second-quarter fiscal 2025 results.BR’s adjusted earnings of $1.6 per share outpaced the consensus mark by 12.2% and increased 69.6% from the year-ago quarter. Total revenues of $1.6 billion surpassed the consensus mark by 3% and rose 12.8% year over year.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.3% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report IQVIA Holdings Inc. (IQV): Free Stock Analysis Report Broadridge Financial Solutions, Inc. (BR): Free Stock Analysis Report Gartner, Inc. (IT): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf IQVIA

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf IQVIA

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu IQVIA Holdings Inc Registered Shs

Wer­bung

Analysen zu IQVIA Holdings Inc Registered Shs

DatumRatingAnalyst
09.10.2018IQVIA BuyUBS AG
02.10.2018IQVIA OutperformRobert W. Baird & Co. Incorporated
25.07.2018IQVIA BuyStifel, Nicolaus & Co., Inc.
DatumRatingAnalyst
09.10.2018IQVIA BuyUBS AG
02.10.2018IQVIA OutperformRobert W. Baird & Co. Incorporated
25.07.2018IQVIA BuyStifel, Nicolaus & Co., Inc.
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für IQVIA Holdings Inc Registered Shs nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"